PhD Veerendra Kumar Reddy will present a webinar introducing Enzene’s commercially validated, fully-connected continuous manufacturing (FCCM) technology, which increases productivity and reduces costs in biologics manufacturing. The EnzeneX platform allows for cost-effective and sustainable production of quality medicines, with the potential to reduce monoclonal antibodies (mAbs) production costs to under $40 per gram.
Kidney dialysis company experiences ransomware attack
Security leaders are analyzing the impact of a ransomware attack on DaVita, revealing operational disruptions and stock market impacts. The attack has raised concerns among
